Position in URGN
as of Jun 30, 2026
· filed Jul 16, 2026
Position Value
$36,836
+$18,839 QoQ
Shares Held
1,001
0.0% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#148
of 186 holders
Holding Since
Jun 2024
9 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in URGN Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Activest Wealth Management holds $750,609 across 68 Biotechnology names. URGN ranks #6 (4.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | QURE |
uniQure N.V.
|
5,000 | $230,300 | |
| 2 | VKTX |
Viking Therapeutics, Inc.
|
1,511 | $58,944 | |
| 3 | AUPH |
Aurinia Pharmaceuticals Inc.
|
3,000 | $50,910 | |
| 4 | CAPR |
Capricor Therapeutics, Inc.
|
2,000 | $48,160 | |
| 5 | KOD |
Kodiak Sciences Inc.
|
1,001 | $38,998 | |
| 6 | URGN |
UroGen Pharma Ltd.
This page
|
1,001 | $36,836 | |
| 7 | ALDX |
Aldeyra Therapeutics, Inc.
|
15,000 | $31,950 | |
| 8 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
58 | $28,810 |
All Filings in URGN
Export CSV
9 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $36,836 | 1,001 | Shares | Sole | 2026-07-16 | |
| 2026-03-31 | $17,997 | 1,001 | Shares | Sole | 2026-04-15 | |
| 2025-12-31 | $23,443 | 1,001 | Shares | Sole | 2026-01-30 | |
| 2025-09-30 | $19,969 | 1,001 | Shares | Sole | 2025-11-03 | |
| 2025-06-30 | $13,713 | 1,001 | Shares | Sole | 2025-07-29 | |
| 2025-03-31 | $11,071 | 1,001 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $10,660 | 1,001 | Shares | Sole | 2025-01-28 | |
| 2024-09-30 | $12,712 | 1,001 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $16,796 | 1,001 | Shares | Sole | 2024-07-30 | |
| No filing history on record for this holder in this stock. | ||||||